Business Brief -- Lidak Pharmaceuticals:
   Accountants Express Doubt
   About Company's Viability
Despite the losses, Lidak Chief Financial Officer Michael
H. Lorber said "we are optimistic about the company's future
in general, and feel that when the financing is completed we
will continue to move forward." Lidak is developing
pharmaceutical products to treat herpes, cancer and AIDS.